Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06584916
PHASE3

A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)

Sponsor: Eli Lilly and Company

View on ClinicalTrials.gov

Summary

The main purpose of this study is to evaluate the efficacy and safety of orforglipron on maintenance of body weight reduction in participants who previously completed treatment with injectable tirzepatide (Zepbound) or injectable semaglutide (Wegovy) in the SURMOUNT-5 trial (NCT05822830).

Official title: A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Orforglipron Once Daily Versus Placebo for Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

376

Start Date

2024-09-13

Completion Date

2025-11-21

Last Updated

2026-06-04

Healthy Volunteers

No

Interventions

DRUG

Orforglipron

Administered orally

DRUG

Placebo

Administered orally

Locations (29)

Cahaba Research

Birmingham, Alabama, United States

Cahaba Research - Pelham

Pelham, Alabama, United States

Southern California Dermatology, Inc.

Santa Ana, California, United States

Encompass Clinical Research

Spring Valley, California, United States

University Clinical Investigators, Inc.

Tustin, California, United States

New Horizon Research Center

Miami, Florida, United States

Rophe Adult and Pediatric Medicine/SKYCRNG

Union City, Georgia, United States

Rocky Mountain Clinical Research

Idaho Falls, Idaho, United States

Iowa Diabetes and Endocrinology Research Center

West Des Moines, Iowa, United States

L-MARC Research Center

Louisville, Kentucky, United States

Arcturus Healthcare , PLC, Troy Internal Medicine Research Division

Troy, Michigan, United States

Prime Health and Wellness/SKYCRNG

Fayette, Mississippi, United States

StudyMetrix Research

City of Saint Peters, Missouri, United States

Palm Research Center Tenaya

Las Vegas, Nevada, United States

Palm Research Center Sunset

Las Vegas, Nevada, United States

Weill Cornell Medical College

New York, New York, United States

PharmQuest Life Sciences, LLC

Greensboro, North Carolina, United States

Lillestol Research

Fargo, North Dakota, United States

Alliance for Multispecialty Research, LLC

Norman, Oklahoma, United States

Tribe Clinical Research, LLC

Greenville, South Carolina, United States

WR-Clinsearch, LLC

Chattanooga, Tennessee, United States

The University of Texas Health Science Center at Houston

Bellaire, Texas, United States

Velocity Clinical Research, Dallas

Dallas, Texas, United States

North Texas Endocrine Center

Dallas, Texas, United States

Biopharma Informatic, LLC

Houston, Texas, United States

PlanIt Research, PLLC

Houston, Texas, United States

Southern Endocrinology Associates

Mesquite, Texas, United States

Puerto Rico Medical Research

Ponce, Puerto Rico

Wellness clinical Research Vega Baja

Vega Baja, Puerto Rico